Maxim Group started coverage on shares of BioNano Genomics (NASDAQ:BNGO) in a note issued to investors on Tuesday, The Fly reports. The firm set a “buy” rating on the stock.
Shares of NASDAQ:BNGO opened at $6.53 on Tuesday. BioNano Genomics has a 52-week low of $5.51 and a 52-week high of $10.00.
BioNano Genomics Company Profile
Read More: What is a Tariff?
Receive News & Ratings for BioNano Genomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNano Genomics and related companies with MarketBeat.com's FREE daily email newsletter.